Page last updated at 22:48 GMT, Thursday, 17 April 2008 23:48 UK

Generic competition hits Pfizer

Drugs made by a Pfizer subsidiary
Thin pipelines and a loss of patent protection is hurting big drugs firms

US drugs giant Pfizer posted an 18% drop in profits for the first three months of 2008 after competition from cheaper patent free products.

The New York-based firm's net income fell to $2.78bn (1.4bn), from $3.39bn in the January to March period.

It blamed the loss of US patent protection to sell blockbuster blood-pressure drug Norvasc and allergy relief medicine Zyrtec.

The loss of exclusivity for key drugs is a concern across the sector.

Pfizer also nursed a worse-than-expected sales decline of flagship cholesterol fighter Lipitor, which generated $300m less revenue than some analysts were expecting.

It insisted that it would meet its previously stated profit targets for the year, helped by a massive cost-cutting programme that has already seen 10,000 jobs go.

The firm's poor performance came despite a boost from the weak dollar which makes sales abroad more valuable.

Shares in the company dropped 3.3% to $20.4, topping the losers on the benchmark Dow Jones index, which closed virtually unchanged in New York, up 1.2 points.


SEE ALSO
Pfizer arrests sought in Nigeria
24 Dec 07 |  Business
Nigeria files new Pfizer claims
20 Jul 07 |  Business
Lipitor slide hits Pfizer profits
18 Jul 07 |  Business

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific